169 related articles for article (PubMed ID: 34997873)
1. Activation of C3 and C5 May Be Involved in the Inflammatory Progression of PCM and GM.
Li XQ; Sun HG; Wang XH; Zhang HJ; Zhang XS; Yu Y; Liu J; Guo QQ; Yang ZL
Inflammation; 2022 Apr; 45(2):739-752. PubMed ID: 34997873
[TBL] [Abstract][Full Text] [Related]
2. MAC mediates mammary duct epithelial cell injury in plasma cell mastitis and granulomatous mastitis.
Zhang HJ; Ding PP; Zhang XS; Wang XC; Sun DW; Bu QA; Li XQ
Int Immunopharmacol; 2022 Dec; 113(Pt A):109303. PubMed ID: 36252469
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
4. C3aR and C5aR1 act as key regulators of human and mouse β-cell function.
Atanes P; Ruz-Maldonado I; Pingitore A; Hawkes R; Liu B; Zhao M; Huang GC; Persaud SJ; Amisten S
Cell Mol Life Sci; 2018 Feb; 75(4):715-726. PubMed ID: 28921001
[TBL] [Abstract][Full Text] [Related]
5. Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4
Hansen CB; Willer A; Bayarri-Olmos R; Kemper C; Garred P
Immunobiology; 2019 Mar; 224(2):307-315. PubMed ID: 30612786
[TBL] [Abstract][Full Text] [Related]
6. The complement C3a and C5a signaling in renal diseases: a bridge between acute and chronic inflammation.
Buelli S; Imberti B; Morigi M
Nephron; 2024 Mar; ():. PubMed ID: 38452744
[TBL] [Abstract][Full Text] [Related]
7. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.
Klos A; Ihrig V; Messner M; Grabbe J; Bitter-Suermann D
J Immunol Methods; 1988 Jul; 111(2):241-52. PubMed ID: 3260926
[TBL] [Abstract][Full Text] [Related]
8. Complement activation in type 1 human diabetes.
Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
[TBL] [Abstract][Full Text] [Related]
9. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
10. Retinal Injury Activates Complement Expression in Müller Cells Leading to Neuroinflammation and Photoreceptor Cell Death.
Tabor SJ; Yuda K; Deck J; Gnanaguru G; Connor KM
Cells; 2023 Jun; 12(13):. PubMed ID: 37443787
[TBL] [Abstract][Full Text] [Related]
11. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
[TBL] [Abstract][Full Text] [Related]
12. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
[TBL] [Abstract][Full Text] [Related]
13. New concepts on the therapeutic control of complement anaphylatoxin receptors.
Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
[TBL] [Abstract][Full Text] [Related]
14. Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions.
Purwar R; Wittmann M; Zwirner J; Oppermann M; Kracht M; Dittrich-Breiholz O; Gutzmer R; Werfel T
J Immunol; 2006 Oct; 177(7):4444-50. PubMed ID: 16982879
[TBL] [Abstract][Full Text] [Related]
15. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
17. Generation of complement fragment C5a in milk is variable among cows.
Rainard P; Poutrel B
J Dairy Sci; 2000 May; 83(5):945-51. PubMed ID: 10821569
[TBL] [Abstract][Full Text] [Related]
18. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
Williams JJ; Yellin SA; Slotman GJ
Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
[TBL] [Abstract][Full Text] [Related]
20. Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.
Zwarthoff SA; Berends ETM; Mol S; Ruyken M; Aerts PC; Józsi M; de Haas CJC; Rooijakkers SHM; Gorham RD
Front Immunol; 2018; 9():1691. PubMed ID: 30083158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
